Mantle cell lymphoma: evolving management strategies
E Campo, S Rule - Blood, The Journal of the American Society …, 2015 - ashpublications.org
Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin's lymphoma that
generally affects older individuals and continues to have one of the worst outcomes of all the …
generally affects older individuals and continues to have one of the worst outcomes of all the …
[HTML][HTML] Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
AA Inamdar, A Goy, NM Ayoub, C Attia, L Oton… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Despite advances in the development of clinical agents for treating Mantle Cell Lymphoma
(MCL), treatment of MCL remains a challenge due to complexity and frequent relapse …
(MCL), treatment of MCL remains a challenge due to complexity and frequent relapse …
[HTML][HTML] ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
To complement the existing treatment guidelines for all tumour types, ESMO organizes
consensus conferences to focus on specific issues in each type of tumour. In this setting, a …
consensus conferences to focus on specific issues in each type of tumour. In this setting, a …
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, C Geisler, O Hermine… - Annals of …, 2014 - annalsofoncology.org
Mantle cell lymphoma (MCL) is a less frequent subtype of lymphoid malignancies and
represents 6%–9% of malignant lymphoma in Western Europe. The annual incidence of this …
represents 6%–9% of malignant lymphoma in Western Europe. The annual incidence of this …
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline
TA Eyre, MJ Bishton… - British Journal …, 2024 - nottingham-repository.worktribe.com
This Guideline was compiled according to the BSH process at https://bs-41 h. org.
uk/media/16732/bsh-guidance-development-process-dec-5-18. pdf and 42 represents best …
uk/media/16732/bsh-guidance-development-process-dec-5-18. pdf and 42 represents best …
[HTML][HTML] ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with …
C Buske, M Hutchings, M Ladetto, V Goede, U Mey… - Annals of …, 2018 - Elsevier
Abstract The European Society for Medical Oncology (ESMO) consensus conference on
mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June …
mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June …
[PDF][PDF] Guidelines for the investigation and management of mantle cell lymphoma
P Mckay, M Leach, R Jackson, G Cook, S Rule… - British journal of …, 2012 - Citeseer
Background The guideline group was selected to be representative of UK-based medical
experts and patients representatives. Ovid MEDLINE, EMBASE and NCBI Pubmed were …
experts and patients representatives. Ovid MEDLINE, EMBASE and NCBI Pubmed were …
Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy
Background. Treatment of splenic marginal zone lymphoma (SMZL) patients is not
standardized. Recent data suggest that rituximab is highly effective and could be considered …
standardized. Recent data suggest that rituximab is highly effective and could be considered …
[PDF][PDF] Guideline for the management of mantle cell lymphoma
P McKay, M Leach, B Jackson, S Robinson, S Rule - Br J Haematol, 2018 - core.ac.uk
Title Page Page 1 Final author’s draft of a paper accepted for publication in the British Journal
of Haematology DOI: ” http://dx.doi.org/10.1111/bjh.15283” McKay et al, BCSH Mantle Cell …
of Haematology DOI: ” http://dx.doi.org/10.1111/bjh.15283” McKay et al, BCSH Mantle Cell …
Thermoresponsive organometallic arene ruthenium complexes for tumour targeting
CM Clavel, E Păunescu, P Nowak-Sliwinska… - Chemical …, 2014 - pubs.rsc.org
Application of mild hyperthermia can increase the cytotoxicity of anticancer drugs in tumour
cells. In this report, we describe low molecular weight thermoactive ruthenium-based drugs …
cells. In this report, we describe low molecular weight thermoactive ruthenium-based drugs …